default author photo

Arjun Puranik

nference, Inc.

One Main Street

East Arcade

Cambridge, MA 02142

United States

SCHOLARLY PAPERS

4

DOWNLOADS

318

TOTAL CITATIONS

14

Scholarly Papers (4)

1.

Casirivimab-Imdevimab Treatment Is Associated with Reduced Rates of Hospitalization Among High-Risk Patients with Mild to Moderate Coronavirus Disease-19

Number of pages: 25 Posted: 01 Jun 2021
Mayo Clinic, nference, Inc., Mayo Clinic, Mayo Clinic, Independent, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, nference, Inc., nference, Inc., Mayo Clinic, Mayo Clinic, Mayo Clinic - College of Medicine and Science, nference, Inc., Mayo Clinic, Mayo Clinic and Mayo Clinic
Downloads 135 (540,814)
Citation 4

Abstract:

Loading...

2.

Enoxaparin Is Associated With Lower Rates of Thrombosis, Kidney Injury, and Mortality Than Unfractionated Heparin in Hospitalized COVID Patients

Number of pages: 21 Posted: 13 Oct 2020
nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., Mayo Clinic, Mayo Clinic and nference, Inc.
Downloads 97 (704,534)

Abstract:

Loading...

COVID-19, anticoagulants, coagulopathy, COVID associated coagulopathy (CAC), heparin, enoxaparin, EHR, electronic health record, physician notes, Artificial Intelligence (AI), EHR curation, Machine Learning, Retrospective EHR curation, Unstructured Text, Unstructured EHRs

3.

Comparison of COVID-19 with Other Leading Causes of Death in the United States

Number of pages: 16 Posted: 30 Apr 2021
nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc. and nference, Inc.
Downloads 54 (1,020,567)

Abstract:

Loading...

4.

Comparison of Two Highly-Effective mRNA Vaccines for COVID-19 During Periods of Alpha and Delta Variant Prevalence

Number of pages: 29 Posted: 10 Aug 2021
nference, Inc., nference, Inc., nference, Inc., nference, Inc., nference, Inc., Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, Mayo Clinic, nference, Inc. and nference, Inc.
Downloads 32 (1,290,922)
Citation 10

Abstract:

Loading...